Op-T LLC

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus	Nutritional and Metabolic Diseases, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, type 1 diabetes mellitus	Recruiting	Phase 2	2026-04-06		NCT06964087
OPT101 in Patients With Community Acquired Pneumonia (CAP) With Sepsis	Community-Acquired Infections, Community-Acquired Pneumonia, Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome, pneumonia, respiratory system disorder, respiratory tract infectious disorder	Not yet recruiting	Phase 1	2025-09-15		NCT06669403

Clinical trials